News

Imperial College London to begin first human trials of new COVID-19 vaccine

At least 300 healthy participants will receive two doses of the vaccine, based on self-amplifying DNA technology, in the next few weeks.

Jun 17, 2020

By : Team ABLE

Marc Princen appointed new Global CEO for Mundipharma

In his new role, Mr Princen will be responsible for all of Mundipharma’s strategic and operational matters globally.

Jun 17, 2020

By : Team ABLE

Jean-Michel Boers is new head of Boehringer Ingelheim

Jean-Michel Boers will succeed Dr. Wolfgang Baiker, who will retire after 31 years of service at Boehringer Ingelheim.

Jun 17, 2020

By : Team ABLE

US Bioeconomic impact is valued at $2.6 trillion dollars: BIO releases new data

As of mid-May 2020, there were more than 400 drug programs in development aimed at eradicating the COVID-19 disease, including 100 vaccine programs and 135 antiviral drug programs

Jun 17, 2020

By : Team ABLE

Gangagen to offer GLP level phage testing service soon

Bangalore based Gangagen Biotechnologies also plans to offer complete characterization of cell bank, that will include the phage testing as a GLP service shortly.

Jun 16, 2020

By : Team ABLE